BETA

HealthcareDrug Manufacturers - Specialty & GenericSmall Cap
BETA DRUGS LIMITED

BETA DRUGS LIMITED (BETA) operates in the Healthcare sector as a Drug Manufacturer - Specialty & Generic. Based in Panchkula, India, the company develops, manufactures, and sells a...

हिन्दी में

BETA DRUGS LIMITED (BETA) Healthcare क्षेत्र में एक विशेषता और जेनेरिक औषधि निर्माता के रूप में कार्य करती है। पंचकूला, भारत में स्थित यह कंपनी भारत में कैंसर-रोधी बल्क ड्रग्स और त...

₹1,950.2+2.75%1D
Previous trading day close · Data updates after market close
1W: -2.7%
1M: -7.5%
6M: +39.9%
1Y: +9.3%
60/100
AverageResearch Score
Market Cap
₹2.1K Cr
Small Cap
P/E Ratio
51.08
Premium
P/B Ratio
10.75
Premium
ROE
24.0%
Strong
ROCE
20.9%
Excellent
Debt / Equity
0.70
Moderate
Div. Yield
N/A
EV/EBITDA
24.29
Fair
52W Low: ₹990.1Current: ₹1,950.252W High: ₹2,807.9
At 53% of 52-week range
Data as of previous trading day close · Updated after market close
📉 Full Technical Chart (RSI, MACD, ADX)
📊
Loading chart...
── Price── SMA50── SMA200Data: Previous trading day close · Updated after market close
Research Score Breakdown
5-factor fundamental analysis — not a buy/sell signal
Quality
ROE, ROCE, margins, cash flow
68/100
Growth
Revenue, EPS, profit growth
77/100
Valuation
PE, PB, EV/EBITDA vs sector
17/100
Risk
Debt levels, volatility, coverage
80/100
News Sentiment
Recent news sentiment
50/100
Weightage: Quality 30% + Growth 25% + Valuation 20% + Risk 15% + News 10%
Mathematical score — not investment advice
Valuation Ratios
P/E Ratio
51.08(Premium)
Forward P/E
N/A
P/B Ratio
10.75(Premium)
P/S Ratio
5.35(Expensive)
EV/EBITDA
24.29(Expensive)
Dividend Yield
N/A
5Y CAGR
44.6%(High growth)
Revenue Growth
7.4%(Moderate)
Profitability
ROE
24.0%(Excellent)
ROCE
20.9%(Excellent)
ROA
12.3%(Efficient)
Net Margin
10.5%(Decent)
EBITDA Margin
21.9%
Financial Health
Debt to Equity
0.70(Moderate)
Current Ratio
3.22(Healthy)
Quick Ratio
2.64(Good)
Interest Coverage
4.55x(Comfortable)
Technical Indicators
Based on previous trading day close
RSI (14)
41(Neutral)
RSI Exp (14)
28(Oversold)
MACD
-64.851(Bearish)
MACD Signal
-55.843
BB Position
8%(Lower band)
BB Width
12.51%(Normal)
ADX (14)
16.3(Sideways)
Williams %R
-53.5(Neutral)
MFI (14)
20(Neutral)
CCI (20)
-270(Oversold)
Stoch %K
47(Neutral)
ATR (14)
100.16(Avg True Range)
OBV (M)
0.9(Positive)
1W OBV Chg
12.3%(Increasing)
Rel Volume
4.08x(High activity)
Volatility
51.1%(High)
Max DD 1Y
-54.2%(High loss)
EMA 200
1878.2
EMA 50
2115.3
SMA 200
1704.0
vs SMA 50
-12.1%(Below SMA50)
vs SMA 200
14.4%(Above SMA200)
Volume
1.59L
Avg Vol 3M
0.4L
Shareholding Pattern
Promoter
59.1%
High confidence
FII
3.0%
DII / MF
6.0%
Share BETA
Share this stock analysis with your network
𝕏 Share on XWhatsAppLinkedIn
⚠️ Research Score is a mathematical fundamental score — not investment advice. Data updates after market close. Please consult a SEBI-registered advisor before investing.